Theraclion SA (ALTHE) - Product Pipeline Analysis, 2023 Update


Theraclion SA (Theraclion) is a medical device company. It designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of malignant tumors. It manufactures and markets echopulse that is used in ambulatory and non-invasive treatment of thyroid nodules and breast fibroadenoma. Theraclion’s echo pulse is used for integrated ultrasound scanners, skin contact and cooling system, scanning arms and motors, among others. It also provides EPack, which ensures cooling and coupling functions; and SONOVEIN, a robotic solution for non-invasive ecotherapy treatment of varicose veins. Theraclion is headquartered in Paris, Ile-de-France, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Theraclion SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Theraclion SA Company Overview
Theraclion SA Company Snapshot
Theraclion SA Pipeline Products and Ongoing Clinical Trials Overview
Theraclion SA – Pipeline Analysis Overview
Theraclion SA - Key Facts
Theraclion SA - Major Products and Services
Theraclion SA Pipeline Products by Development Stage
Theraclion SA Ongoing Clinical Trials by Trial Status
Theraclion SA Pipeline Products Overview
EchoPulse - Breast Tumor
EchoPulse - Breast Tumor Product Overview
EchoPulse - Breast Tumor Clinical Trial
EchoPulse - Thyroid Nodule
EchoPulse - Thyroid Nodule Product Overview
EchoPulse - Thyroid Nodule Clinical Trial
Sonovein HD
Sonovein HD Product Overview
SONOVEIN System - Varicose Veins
SONOVEIN System - Varicose Veins Product Overview
SONOVEIN System - Varicose Veins Clinical Trial
Theraclion SA - Key Competitors
Theraclion SA - Key Employees
Theraclion SA - Locations And Subsidiaries
Head Office
Recent Developments
Theraclion SA, Recent Developments
Jan 29, 2024: Theraclion Pursues Its Strategy and Announces Its 2023 Revenue
Oct 24, 2023: Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated With SONOVEIN as Part of the FDA-approved Pivotal Study
Oct 11, 2023: Theraclion Announces Its Half-year Financial Results for 2023 and Provides an Update on the Execution of Its Strategy
Apr 18, 2023: Theraclion wins FDA IDE approval for varicose veins study
Jan 30, 2023: Theraclion announces results of first US trial
Jan 16, 2023: Theraclion reaches major milestones in 2022, paving the way for the commercial deployment of SONOVEIN
Oct 17, 2022: THERACLION: Last patient of first SONOVEIN US study has been treated
Sep 29, 2022: Theraclion: New echotherapy for varicose veins partnership with Parisian Region Hospital Wound Center announced
Jun 13, 2022: THERACLION: HIFU and their Use in Immune-oncology Presented at the Annual Scientific Meeting of the Society of Interventional Radiology in Boston
May 16, 2022: Theraclion launches Its new robotic vein platform SONOVEIN HD
About GlobalData
Contact Us
List of Tables
Table 1: Theraclion SA Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Theraclion SA Pipeline Products by Equipment Type
Table 3: Theraclion SA Pipeline Products by Indication
Table 4: Theraclion SA, Key Facts
Table 5: Theraclion SA, Major Products and Services
Table 6: Theraclion SA Number of Pipeline Products by Development Stage
Table 7: Theraclion SA Pipeline Products Summary by Development Stage
Table 8: Theraclion SA Ongoing Clinical Trials by Trial Status
Table 9: Theraclion SA Ongoing Clinical Trials Summary
Table 10: EchoPulse - Breast Tumor - Product Status
Table 11: EchoPulse - Breast Tumor - Product Description
Table 12: EchoPulse - Breast Tumor - Focused Ultrasound with Low-dose Gemcitabine to Augment Immune Control of Early Stage Breast Cancer
Table 13: EchoPulse - Breast Tumor - Pilot Evaluation of Focused Ultrasound Ablation and Focused Ultrasound Ablation Plus PD-1 Antibody Blockade in Advanced Solid Tumors
Table 14: EchoPulse - Breast Tumor - Treatment of Breast Fibroadenoma Targeted Tissue with High Intensity Focused Ultrasound (HIFU)
Table 15: EchoPulse - Thyroid Nodule - Product Status
Table 16: EchoPulse - Thyroid Nodule - Product Description
Table 17: EchoPulse - Thyroid Nodule - A Multi-center, Randomized, Controlled Trial of High Intensity Focused Ultrasound (HIFU) Treatment of Benign Thyroid Nodules
Table 18: Sonovein HD - Product Status
Table 19: Sonovein HD - Product Description
Table 20: SONOVEIN System - Varicose Veins - Product Status
Table 21: SONOVEIN System - Varicose Veins - Product Description
Table 22: SONOVEIN System - Varicose Veins - A Pivotal Study to Evaluate the Effects of the SONOVEIN System for Treatment of Varicose Veins
Table 23: Theraclion SA, Key Employees
Table 24: Glossary
List of Figures
Figure 1: Theraclion SA Pipeline Products by Equipment Type
Figure 2: Theraclion SA Pipeline Products by Development Stage
Figure 3: Theraclion SA Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings